Clinical and Pathological Features of Breast Cancer Associated with the Pathological Complete Response to Anthracycline-Based Neoadjuvant Chemotherapy

Publisher： Karger

E-ISSN： 1423-0232|81|1|30-38

ISSN： 0030-2414

Source： Oncology, Vol.81, Iss.1, 2011-09, pp. : 30-38

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumor Topoisomerase II Alpha Status and Response to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer

By  

Oncology, Vol. 80, Iss. 3-4, 2011-07 ,pp. : 269-277

Karger

Access to resources Recommend Favorite

Serial Topoisomerase II Expression in Primary Breast Cancer and Response to Neoadjuvant Anthracycline-Based Chemotherapy

By  

Oncology, Vol. 66, Iss. 5, 2004-09 ,pp. : 388-394

Karger

Access to resources Recommend Favorite

Prognostic Significance of Neutropenia on Day One of Anthracycline-Based Neoadjuvant Chemotherapy in Operable Breast Cancer

By  

Oncology, Vol. 78, Iss. 3-4, 2010-04 ,pp. : 213-219

Karger

Access to resources Recommend Favorite

Diffusion‐weighted imaging in assessing pathological response of tumor in breast cancer subtype to neoadjuvant chemotherapy

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 42, Iss. 3, 2015-09 ,pp. : 779-787

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is the Standardized Uptake Value of FDG-PET/CT Predictive of Pathological Complete Response in Locally Advanced Rectal Cancer Treated with Capecitabine-Based Neoadjuvant Chemoradiation?

By  

Oncology, Vol. 84, Iss. 4, 2013-01 ,pp. : 191-199

Karger

Access to resources Recommend Favorite